Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion description "[Trastuzumab is considered effective against human epidermal growth factor receptor (HER)-2-positive breast cancer as assessed by immunohistochemistry (IHC) and fluorescence or chromogenic in situ hybridization (FISH/CISH) on biopsy material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion evidence source_evidence_literature NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion SIO_000772 18448549 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion wasDerivedFrom befree-2016 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion wasGeneratedBy ECO_0000203 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- befree-2016 importedOn "2016-02-19" NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.